Kathryn Volkening

Professor-part time

Fanshawe College

Canada

Research Interests

Explore related searches

Professors in Canada

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Kathryn Volkening is a part-time Professor at Fanshawe College in Canada. Her research areas focus on the isolation and characterization of extracellular vesicles, drug delivery systems utilizing metal-organic frameworks, and the pathophysiology of neurodegenerative diseases such as ALS. Recent publications highlight innovative techniques in cerebrospinal fluid sampling and the biochemical mechanisms underlying tau protein metabolism and its implications in brain injury and disease.

Articles (10)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (3)

Gunna Christiansen

Aalborg University

DENMARK

View details

Michael J. Strong

Western University

CANADA

View details

Stephen Pasternak

Associate Professor

Western University

CANADA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Kathryn Volkening

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

A methodological primer of extracellular vesicles isolation and characterization via different techniques

A technique for repeated blood and cerebrospinal fluid sampling from individual rats over time without the need for repeated anesthesia

New metal-organic framework coated sodium alginate for the delivery of curcumin as a sustainable drug delivery and cancer therapy system

The development of a bio-based metal-organic framework coated with carboxymethyl cellulose with the ability to deliver curcumin with anticancer properties

Upregulation of LRRK2 following traumatic brain injury does not directly phosphorylate Thr<sup>175</sup> tau

Evidence of synergism among three genetic variants in a patient with LMNA-related lipodystrophy and amyotrophic lateral sclerosis leading to a remarkable nuclear phenotype

Tau protein phosphorylation at Thr175 initiates fibril formation via accessibility of the N‐terminal phosphatase‐activating domain

Inclusion Formation and Toxicity of the ALS Protein RGNEF and Its Association with the Microtubule Network

Alterations in Tau Metabolism in ALS and ALS-FTSD

Neurofilament Immunohistochemistry Followed by Luxol Fast Blue, for Staining Axons and Myelin in the Same Paraffin Section of Spinal Cord

Collaborators (3)

Gunna Christiansen

Michael J. Strong

Stephen Pasternak

Make your next move.